Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents
- Conditions
- Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis
- Interventions
- Biological: OriginatorBiological: Biosimilar
- First Posted Date
- 2018-03-20
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- Opal Rheumatology Ltd.
- Target Recruit Count
- 5000
- Registration Number
- NCT03470688
- Locations
- 🇦🇺
Susan Street Specialists Centre, Camperdown, New South Wales, Australia
🇦🇺Hills Rheumatology, Castle Hill, New South Wales, Australia
🇦🇺Orthopaedic and Arthritis Centre, Chatswood, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath